016: Can A Biosimilars Shared Savings Model Work In The U.S.?
Source: Life Science Leader
Anna Rose Welch talks about a new whitepaper that explains why now is the best time for a U.S. biosimilars shared savings model.
Show References & Notes:
Why It's Time For A U.S. Biosimilar Shared Savings Model
The whitepaper by Matrix Global Advisor’s Alex Brill
Email Anna Rose Welch at anna.welch@lifescienceconnect.com
Music in this episode provided by Abby Wright.
This website uses cookies to ensure you get the best experience on our website. Learn more